Loading viewer...
conference
Format: PDF conference
Hansa Biopharma presents its clinical-stage immunology pipeline and recently approved Idefirix for kidney transplantation in Europe. The company highlights its validated technology platform, expanded organization of 145 employees, and strong cash position through 2024, with applications across transplantation and autoimmune diseases.
SALGA SDG Implementation Governance 2024
conferenceconference
14 Pages
SALGA (South African Local Government Association)
investor_presentation
15 Pages
Hansa Biopharma Investor Presentation — April 2024
investor_presentationinvestor_presentation
99 Pages
conference
21 Pages
DHI Group
Summit Wireless Technologies WISA 2021 Benzinga Reopening Stocks Summit
conferenceconference
23 Pages
Summit Wireless Technologies, Inc.
First Horizon National Corporation Goldman Sachs 2016
conferenceconference
22 Pages
First Horizon National Corporation